Cargando…
Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
AIMS: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements has an effect on lumbar spine and hip bone mineral density (BMD) in ankylosing spondylitis (AS) patients starting tumour necrosis factor‐α inhibitors or receiving conventional treatm...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328658/ https://www.ncbi.nlm.nih.gov/pubmed/32530102 http://dx.doi.org/10.1111/bcp.14431 |
_version_ | 1784757772392333312 |
---|---|
author | Arends, Suzanne Wink, Freke Veneberg, Joyce Bos, Reinhard van Roon, Eric van der Veer, Eveline Maas, Fiona Spoorenberg, Anneke |
author_facet | Arends, Suzanne Wink, Freke Veneberg, Joyce Bos, Reinhard van Roon, Eric van der Veer, Eveline Maas, Fiona Spoorenberg, Anneke |
author_sort | Arends, Suzanne |
collection | PubMed |
description | AIMS: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements has an effect on lumbar spine and hip bone mineral density (BMD) in ankylosing spondylitis (AS) patients starting tumour necrosis factor‐α inhibitors or receiving conventional treatment. Secondly, to explore the development of radiographic vertebral fractures. METHODS: Patients from the Groningen Leeuwarden AS cohort receiving bisphosphonates based on clinical indication and available 2‐year follow‐up BMD measurements were included. BMD of lumbar spine (L1–L4) and hip (total proximal femur) were measured using dual‐energy X‐ray absorptiometry. Spinal radiographs (Th4–L4) were scored for vertebral fractures according to the Genant method. RESULTS: In the 20 included patients (median 52 years, 14 males), lumbar spine and hip BMD Z‐scores increased significantly; median from −1.5 (interquartile range [IQR] −2.2 to 0.4) to 0.1 (IQR −1.5 to 1.0); P < .001 and median from −1.0 (IQR −1.6 to −0.7) to −0.8 (IQR −1.2 to 0.0); P = .006 over 2 years, respectively. In patients also treated with tumour necrosis factor‐α inhibitors (n = 11), lumbar spine and hip BMD increased significantly (median 2‐year change +8.6% [IQR 2.4 to 19.6; P = .009] and +3.6% [IQR 0.7–9.0; P = .007]). In patients on conventional treatment (n = 9), lumbar spine BMD increased significantly (median 2‐year change +3.6%; IQR 0.7 to 9.0; P = .011) and no improvement was seen in hip BMD (median −0.6%; IQR −3.1 to 5.1; P = .61). Overall, younger AS males with limited spinal radiographic damage showed most improvement in lumbar spine BMD. Four mild radiographic vertebral fractures developed in 3 patients and 1 fracture increased from mild to moderate over 2 years in postmenopausal women and middle‐aged men. CONCLUSION: This explorative observational cohort study in AS showed that 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements significantly improves lumbar spine BMD. Mild radiographic vertebral fractures still occurred. |
format | Online Article Text |
id | pubmed-9328658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93286582022-07-30 Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis Arends, Suzanne Wink, Freke Veneberg, Joyce Bos, Reinhard van Roon, Eric van der Veer, Eveline Maas, Fiona Spoorenberg, Anneke Br J Clin Pharmacol Original Articles AIMS: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements has an effect on lumbar spine and hip bone mineral density (BMD) in ankylosing spondylitis (AS) patients starting tumour necrosis factor‐α inhibitors or receiving conventional treatment. Secondly, to explore the development of radiographic vertebral fractures. METHODS: Patients from the Groningen Leeuwarden AS cohort receiving bisphosphonates based on clinical indication and available 2‐year follow‐up BMD measurements were included. BMD of lumbar spine (L1–L4) and hip (total proximal femur) were measured using dual‐energy X‐ray absorptiometry. Spinal radiographs (Th4–L4) were scored for vertebral fractures according to the Genant method. RESULTS: In the 20 included patients (median 52 years, 14 males), lumbar spine and hip BMD Z‐scores increased significantly; median from −1.5 (interquartile range [IQR] −2.2 to 0.4) to 0.1 (IQR −1.5 to 1.0); P < .001 and median from −1.0 (IQR −1.6 to −0.7) to −0.8 (IQR −1.2 to 0.0); P = .006 over 2 years, respectively. In patients also treated with tumour necrosis factor‐α inhibitors (n = 11), lumbar spine and hip BMD increased significantly (median 2‐year change +8.6% [IQR 2.4 to 19.6; P = .009] and +3.6% [IQR 0.7–9.0; P = .007]). In patients on conventional treatment (n = 9), lumbar spine BMD increased significantly (median 2‐year change +3.6%; IQR 0.7 to 9.0; P = .011) and no improvement was seen in hip BMD (median −0.6%; IQR −3.1 to 5.1; P = .61). Overall, younger AS males with limited spinal radiographic damage showed most improvement in lumbar spine BMD. Four mild radiographic vertebral fractures developed in 3 patients and 1 fracture increased from mild to moderate over 2 years in postmenopausal women and middle‐aged men. CONCLUSION: This explorative observational cohort study in AS showed that 2 years of treatment with bisphosphonates in combination with calcium/vitamin D supplements significantly improves lumbar spine BMD. Mild radiographic vertebral fractures still occurred. John Wiley and Sons Inc. 2020-07-05 2021-02 /pmc/articles/PMC9328658/ /pubmed/32530102 http://dx.doi.org/10.1111/bcp.14431 Text en © 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Arends, Suzanne Wink, Freke Veneberg, Joyce Bos, Reinhard van Roon, Eric van der Veer, Eveline Maas, Fiona Spoorenberg, Anneke Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
title | Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
title_full | Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
title_fullStr | Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
title_full_unstemmed | Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
title_short | Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
title_sort | bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328658/ https://www.ncbi.nlm.nih.gov/pubmed/32530102 http://dx.doi.org/10.1111/bcp.14431 |
work_keys_str_mv | AT arendssuzanne bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT winkfreke bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT venebergjoyce bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT bosreinhard bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT vanrooneric bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT vanderveereveline bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT maasfiona bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis AT spoorenberganneke bonemineraldensityimprovesduring2yearsoftreatmentwithbisphosphonatesinpatientswithankylosingspondylitis |